Harvest Fund Management Co. Ltd boosted its stake in RadNet, Inc. (NASDAQ:RDNT - Free Report) by 112.0% during the third quarter, according to its most recent 13F filing with the SEC. The firm owned 13,495 shares of the medical research company's stock after acquiring an additional 7,128 shares during the quarter. Harvest Fund Management Co. Ltd's holdings in RadNet were worth $936,000 as of its most recent filing with the SEC.
Several other hedge funds have also recently modified their holdings of RDNT. Cerity Partners LLC increased its stake in shares of RadNet by 131.4% in the 3rd quarter. Cerity Partners LLC now owns 387,536 shares of the medical research company's stock worth $26,891,000 after acquiring an additional 220,068 shares during the last quarter. Citigroup Inc. grew its holdings in shares of RadNet by 23.0% in the third quarter. Citigroup Inc. now owns 174,878 shares of the medical research company's stock valued at $12,135,000 after purchasing an additional 32,673 shares in the last quarter. Eagle Asset Management Inc. increased its position in shares of RadNet by 9.7% during the third quarter. Eagle Asset Management Inc. now owns 262,899 shares of the medical research company's stock worth $19,068,000 after acquiring an additional 23,300 shares during the period. Intech Investment Management LLC boosted its stake in shares of RadNet by 178.3% in the 3rd quarter. Intech Investment Management LLC now owns 21,078 shares of the medical research company's stock valued at $1,463,000 after buying an additional 13,505 shares during the period. Finally, Moran Wealth Management LLC grew its holdings in RadNet by 27.3% during the 3rd quarter. Moran Wealth Management LLC now owns 9,986 shares of the medical research company's stock worth $693,000 after acquiring an additional 2,142 shares in the last quarter. Institutional investors and hedge funds own 77.90% of the company's stock.
RadNet Stock Down 0.0 %
Shares of RDNT traded down $0.02 during mid-day trading on Tuesday, reaching $81.45. The company's stock had a trading volume of 363,750 shares, compared to its average volume of 552,343. RadNet, Inc. has a 1 year low of $32.01 and a 1 year high of $93.65. The company has a quick ratio of 2.16, a current ratio of 2.16 and a debt-to-equity ratio of 0.89. The company has a market cap of $6.03 billion, a price-to-earnings ratio of -1,163.86 and a beta of 1.75. The business has a fifty day moving average of $71.32 and a 200 day moving average of $64.41.
Insider Transactions at RadNet
In related news, insider Ranjan Jayanathan sold 38,557 shares of the firm's stock in a transaction on Tuesday, November 19th. The stock was sold at an average price of $80.00, for a total transaction of $3,084,560.00. Following the sale, the insider now owns 192,724 shares of the company's stock, valued at approximately $15,417,920. This trade represents a 16.67 % decrease in their position. The sale was disclosed in a filing with the SEC, which can be accessed through this link. 5.12% of the stock is owned by insiders.
Analyst Ratings Changes
RDNT has been the topic of a number of research reports. Sidoti upgraded shares of RadNet to a "strong-buy" rating in a research report on Friday, October 4th. Barclays raised shares of RadNet from an "equal weight" rating to an "overweight" rating and increased their target price for the company from $57.00 to $79.00 in a report on Friday, September 6th. Jefferies Financial Group boosted their price objective on shares of RadNet from $75.00 to $80.00 and gave the stock a "buy" rating in a research report on Thursday, September 19th. Finally, Truist Financial raised their price target on RadNet from $70.00 to $80.00 and gave the stock a "buy" rating in a research report on Monday, September 23rd. One research analyst has rated the stock with a sell rating, four have given a buy rating and one has issued a strong buy rating to the company. According to MarketBeat, the stock currently has a consensus rating of "Moderate Buy" and an average price target of $74.75.
Read Our Latest Stock Analysis on RDNT
RadNet Profile
(
Free Report)
RadNet, Inc, together with its subsidiaries, provides outpatient diagnostic imaging services in the United States. The company operates in two segments: Imaging Centers and Artificial Intelligence. Its services include magnetic resonance imaging, computed tomography, positron emission tomography, nuclear medicine, mammography, ultrasound, diagnostic radiology, fluoroscopy, and other related procedures, as well as multi-modality imaging services.
See Also
Before you consider RadNet, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and RadNet wasn't on the list.
While RadNet currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Growth stocks offer a lot of bang for your buck, and we've got the next upcoming superstars to strongly consider for your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.